The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial | PLOS ONE
![CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01483-x/MediaObjects/41416_2021_1483_Fig1_HTML.png)
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer
![Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-59031-1/MediaObjects/41598_2020_59031_Fig3_HTML.png)
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
![Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery | Radiation Oncology | Full Text Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1748-717X-8-43/MediaObjects/13014_2012_Article_771_Fig2_HTML.jpg)
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery | Radiation Oncology | Full Text
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-3.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
Colorectal Hyperplasia and Dysplasia Due to Human Carcinoembryonic Antigen ( CEA) Family Member Expression in Transgenic Mice | PLOS ONE
![A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts | Scientific Reports A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-48285-z/MediaObjects/41598_2019_48285_Fig1_HTML.png)
A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts | Scientific Reports
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-4.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity: Molecular Therapy - Oncolytics Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/d502b2b3-2c4d-4548-8f81-618c4b18cac1/gr3.jpg)
Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity: Molecular Therapy - Oncolytics
![Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin | Anticancer Research Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/3/1711/F1.large.jpg)
Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin | Anticancer Research
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr2.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-019-05357-y/MediaObjects/10549_2019_5357_Fig2_HTML.png)
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink
![Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-59031-1/MediaObjects/41598_2020_59031_Fig1_HTML.png)